Home » News » CROs/Service Providers » Campbell Alliance forms suite of services for product launches

Campbell Alliance forms suite of services for product launches

Monday, February 2, 2015

Campbell Alliance, the consulting arm of inVentiv Health, has formed the Campbell Alliance Launch Suite, an integrated offering designed to bring products to market primed for success.

As pharmaceutical companies face patent expiries and shrinking pipelines, product launches are a critical component for growth. With over 400 launches on the horizon in the next three years, it will be crucial for pharmaceutical companies to capture the full value from each launch.

More than a decade ago, Campbell Alliance pioneered the Launch Playbook, and claims this strategic planning process and project management tool has resulted in clients experiencing an average of 45% improvement in time to launch when compared to launches of similar drugs that went to market without using the Launch Playbook. Campbell Alliance built on this best-in-class offering to create a comprehensive launch suite for clients preparing to commercialize a new product in the current complex, crowded and competitive healthcare marketplace.

“Biopharmaceutical companies know that to successfully launch a product in the new healthcare environment, they need to redefine how they commercialize assets,” said Michael Griffith, executive vice president of inVentiv Health and president of the commercial division. “The Campbell Alliance Suite is one offering of our contract commercial organization (CCO), an outsourcing model that realizes efficiencies to accelerate performance and delivery. We have seen that enhanced commercialization leads to enhanced value.”

The suite pairs strategic insights and tools, informed by planning launches for nearly 60% of new U.S. molecular entities and more than 500 global launch engagements. The scalable offering allows clients to tap into experts who have managed launches across a wide range of product types, geographic markets and therapeutic areas. The suite, which is centered on a proprietary launch framework, includes:

• Launch Strategy: Insights and business-driven global and market-level launch strategy, with a focus on therapeutic areas, as well as product categories (e.g., rare diseases, biosimilars and small footprint launches).

• Launch Planning: Leveraging the Launch Playbook process and upgraded project management platform, Campbell guides clients in developing global launch plans, assessing launch readiness and developing risk mitigation plans. The web-based Launch Playbook tool features a new dashboard section for improved project management, risk tracking and enhanced reporting.

• Launch Management: Seamless launch execution, utilizing the right tools and methodologies to develop meaningful key performance indicators and diagnose progress.

• Launch Excellence: Institutionalization of Launch Excellence within an organization by establishing the foundational launch elements for developing strategy, planning and management.

“With the strategic recommendations from our launch and subject matter experts, we help clients design and assess their overall launch strategy, track and gauge their progress to launch and achieve critical outcomes,” said Rohit Sood, head of Global Launch Excellence at Campbell Alliance. “Launches are a key milestone in the success of an asset, and we recognize that the scope of each launch varies by asset and market. We fully adapt our approach and solutions to each client’s business objectives and organizational footprint.”

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!